As for the latter, we have preliminary evidence that the frequency of nuclear jun-positive cells significantly increases in cells treated with the leukaemia inhibitory factor and connective tissue growth factor, respectively, in both cases accompanied by marked increase in anchorage-independent clonogenicity. This evidence concerns the gene CCN2 and leukemia.